Retatrutide — Triple-Agonist Research Peptide (GLP-1 / GIP / Glucagon Pathways)

Retatrutide is a next-generation research peptide studied for its interaction with the GLP-1, GIP, and glucagon pathways. This triple-agonist profile has made it a subject of interest in scientific and metabolic research delivering powerful weight loss, appetite suppression, and metabolic regulation.

How to Use

Start with 2 mg once weekly for the first 2 weeks, then increase gradually based on your comfort and response.

Cycle Duration

Long-term use is typical, with a minimum suggested duration of at least 1 month to see the result.

Estimated Vial Duration

A 12 mg vial typically lasts 6–8 weeks, depending on your weekly dosage.

Potential Side Effects

Some users may experience mild gastrointestinal effects, nausea, or fatigue.

Personalized Plan Included

Every purchase comes with a free personalized plan. Please visit the FAQ page for details on how to receive yours.

What You Will Receive

Each vial includes a complimentary pack of sterile, medical-grade syringes (10 per pack). All vials are shipped without external labels for safety and secure handling.